Home > Insider Trading > Filing (0001415889-24-028929)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1623526	Stoke Therapeutics Inc.	STOK	Pharmaceutical Preparations (2834)	471144582

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1966716	Jonathan Allan	C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730	General Counsel & Corp Sec	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-12-09	12,114	$13.69	23,028	No	4	S	Direct
Common Stock	Disposition	2024-12-09	1,552	$12.99	21,476	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.41 to $14.22 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote (4).
The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.99 to $13.24 per share, inclusive.